[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
Re: Fwd: Results of the NIH Plan
- To: <SPARC-OAForum@arl.org>, <heatherm@eln.bc.ca>
- Subject: Re: Fwd: Results of the NIH Plan
- From: "Peter Banks" <pbanks@diabetes.org>
- Date: Thu, 15 Sep 2005 18:49:34 EDT
- Reply-to: liblicense-l@lists.yale.edu
- Sender: owner-liblicense-l@lists.yale.edu
I do not think it is primarily the responsibility of publishers to publicize and promote the submission requirements of NIH or any other funding agency. Nonetheless, I think ADA (like many publishers) has made every reasonable effort to make authors aware of the plan and to eliminate any barrier to their participation. Specifically, we inform authors of our policy regarding deposit of manuscripts --in each acceptance letter (as of late March), which, by definition, informs the author that the final, accepted version is available --in the instructions for authors. (see http://diabetes.diabetesjournals.org/misc/ifora.shtml#Section3) --on the copyright assignment form (printed in each issue and online as of May) We also published the announcement from ADA's Publications Policy Committee regarding the NIH policy in the August issues of Diabetes Care and Diabetes. I believe we have provided "clear, helpful" information. That doesn't mean we are actively promoting self-archiving, which is more properly the role of SPARC or others who wish to advance that cause. But we have certainly done everything we can to help our authors comply with the requirements of any funding body. Peter Banks Publisher American Diabetes Association Email: pbanks@diabetes.org >>> Heather Morrison <heatherm@eln.bc.ca> 09/15/05 1:27 PM >>> It would be most helpful if publishers such as Peter Banks would provide information about what they are doing to facilitate author submission of articles. For example, is the ADA notifying NIH-funded authors when the final version is available, and providing a copy along with a note clarifying that this is the copy ADA would like to see in PMC? It is difficult, at best, to eliminate bias in science. This is why the double-blind experimental method was developed. If an experimenter prefers one outcome, the evidence is that that outcome becomes more likely. A publishers who finds open access worrying is unlikely to conduct unbiased research on an open access policy. For example, the data Peter presents below could easily be explained by confusion on the part of authors; perfectly understandable confusion, when the publisher is not interested in providing clear, helpful information. My experience with publishers has been that they do notify authors when this is necessary for the publishers' purposes (e.g., a signed agreement is needed), however they are not quick to notify authors when an article has been published. It has happened to me that the first notice I had an article of mine was published was when it was cited in Open Access News, or when I received a paper copy - sometimes months after the publication date. best, Heather Morrison _____________________ On 14-Sep-05, at 6:30 PM, Peter Banks wrote: I thought it might be interesting to share the American Diabetes Association's experience with the PMC system for author manuscriupts, since ADA is fairly unusual in allowing authors to post their accepted manuscript immediately upon acceptance. Thus, the posting of Diabetes and Diabetes Care papers on PMC shows how successful the NIH system is absent any publisher-mandated delay. The success of the system with articles in our journals goes to the question of whether author failure to comply with the system can be attributed to publishers, or rather to the resistance of researchers and universities to comply with the system. Since the PMC system's debut, Diabetes has accepted 134 original articles, and Diabetes Care has accepted 122. In 2004, 39% of Diabetes manuscripts were NIH funded, as were 15% of Diabetes Care manuscripts. Using those percentages, we would expect that 53 Diabetes manuscripts and 18 Diabetes Care manuscripts were NIH funded since the start of the PMC system. To date, one author manuscript from either journal has been posted on PMC. Chu K, Tsai MJ. Related Articles, Links Neuronatin, a downstream target of BETA2/NeuroD1 in the pancreas, is involved in glucose-mediated insulin secretion. Diabetes. 2005 Apr;54(4):1064-73. PMID: 15793245 [PubMed - indexed for MEDLINE] [Incidentally, it is the wrong version of the manuscript.] My conclusion is that lack of compliance with the NIH plan is primarily the responsibility of NIH. I suspect that researchers are not at all convinced of the value of the system [researchers I know are openly hostile to it, and see it as yet another bureaucratic burden or little benefit to them]. It may also be that the manuscript submission system or the PMC site itself is not perceived as user-friendly. Peter Banks American Diabetes Association Email: pbanks@diabetes.org American Diabetes Association Cure. Care. Commitment. Visit us at http://diabetes.org Or Call 1-800-DIABETES (800-342-2383)
- Prev by Date: Fwd: Do governments subsidize journals (was: Who gets hurt by Open
- Next by Date: Re: Results of the NIH Plan
- Previous by thread: Re: Results of the NIH Plan
- Next by thread: Re: Results of the NIH Plan
- Index(es):